Cartesian Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Cartesian Therapeutics, Inc. (RNAC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.94 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- Cartesian Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 7.94M shares, a 6.02% increase year-over-year.
- Cartesian Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 9.44M shares, a 15.00% increase year-over-year.
- Cartesian Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 8.11M shares, a 13.48% decline year-over-year.
- Cartesian Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 7.49M shares, a 3.22% increase year-over-year.
- Cartesian Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 8.15M shares, a 11.54% increase from fiscal 2024.
- Cartesian Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 7.31M shares, a 63.64% decline from fiscal 2023.
- Cartesian Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 20.10M shares, a 11.57% increase from fiscal 2022.
- Cartesian Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 18.01M shares, a 18.96% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 7.94M shares 10-Q · filed 2026-08-06 | 9.03M shares 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 9.44M shares 10-Q · filed 2026-04-30 | |||||||
| 2025-12-31 | 8.15M shares 10-K · filed 2026-03-09 | |||||||
| 2025-09-30 | 8.11M shares 10-Q · filed 2025-11-06 | 8.11M shares 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | 7.49M shares 10-Q · filed 2026-08-06 | 8.19M shares 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | 8.20M shares 10-Q · filed 2026-04-30 | |||||||
| 2024-12-31 | 7.31M shares 10-K · filed 2026-03-09 | |||||||
| 2024-09-30 | 9.38M shares 10-Q · filed 2025-11-06 | 9.38M shares 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | 7.26M shares 10-Q · filed 2025-08-07 | 8.86M shares 10-Q · filed 2025-08-07 | ||||||
| 2024-03-31 | 21.07M shares 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | 20.10M shares 10-K · filed 2025-03-13 | 602.90M shares 10-K · filed 2024-03-07 | ||||||
| 2023-09-30 | 1.78M shares 10-Q · filed 2024-11-07 | 53.26M shares 10-Q · filed 2023-11-13 | 1.78M shares 10-Q · filed 2024-11-07 | 53.26M shares 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | 1.79M shares 10-Q · filed 2024-08-08 | 53.84M shares 10-Q · filed 2023-08-17 | 1.79M shares 10-Q · filed 2024-08-08 | 53.84M shares 10-Q · filed 2023-08-17 | ||||
| 2023-03-31 | 1.81M shares 10-Q · filed 2024-05-08 | 54.43M shares 10-Q · filed 2023-05-04 | ||||||
| 2022-12-31 | 18.01M shares 10-K · filed 2024-03-07 | |||||||
| 2022-09-30 | 47.38M shares 10-Q · filed 2023-11-13 | 17.17M shares 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | 47.73M shares 10-Q · filed 2023-08-17 | 37.52M shares 10-Q · filed 2023-08-17 | ||||||
| 2022-03-31 | 15.59M shares 10-Q · filed 2023-05-04 | |||||||
| 2021-12-31 | 22.23M shares 10-K · filed 2024-03-07 | |||||||
| 2021-09-30 | 24.08M shares 10-Q · filed 2022-11-03 | 24.08M shares 10-Q · filed 2022-11-03 | ||||||
| 2021-06-30 | 10.87M shares 10-Q · filed 2022-08-08 | 22.95M shares 10-Q · filed 2022-08-08 | ||||||
| 2021-03-31 | 23.24M shares 10-Q · filed 2022-05-05 | 23.11M shares 10-Q · filed 2021-05-13 | ||||||
| 2020-12-31 | 20.29M shares 10-K · filed 2023-03-02 | 20.24M shares 10-K · filed 2021-03-12 | ||||||
| 2020-09-30 | 21.53M shares 10-Q · filed 2021-11-09 | 21.53M shares 10-Q · filed 2021-11-09 | 21.47M shares 10-Q · filed 2020-11-05 | |||||
| 2020-06-30 | 22.51M shares 10-Q · filed 2021-08-12 | 22.51M shares 10-Q · filed 2021-08-12 | 22.47M shares 10-Q · filed 2020-08-06 | |||||
| 2020-03-31 | 31.00M shares 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | 30.09M shares 10-K · filed 2022-03-10 | 30.06M shares 10-K · filed 2020-03-12 | ||||||
| 2019-09-30 | 5.68M shares 10-Q · filed 2020-11-05 | |||||||
| 2019-06-30 | 5.01M shares 10-Q · filed 2020-08-06 | |||||||
| 2019-03-31 | 4.94M shares 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | 4.36M shares 10-K · filed 2021-03-12 | |||||||
| 2018-09-30 | 3.40M shares 10-Q · filed 2019-11-08 | |||||||
| 2018-06-30 | 3.46M shares 10-Q · filed 2019-08-08 | |||||||
| 2018-03-31 | 2.83M shares 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | 2.83M shares 10-K · filed 2020-03-12 | |||||||
| 2017-09-30 | 2.60M shares 10-Q · filed 2018-11-08 | |||||||
| 2017-06-30 | 2.32M shares 10-Q · filed 2018-08-08 | |||||||
| 2017-03-31 | 2.12M shares 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | 2.23M shares 10-K · filed 2019-03-15 | |||||||
| 2016-09-30 | 2.25M shares 10-Q · filed 2017-11-07 | |||||||
| 2016-06-30 | 2.23M shares 10-Q · filed 2017-08-11 | |||||||
| 2016-03-31 | 12.30M shares 10-Q · filed 2017-05-11 | |||||||
| 2015-12-31 | 12.14M shares 10-K · filed 2018-03-15 | |||||||
| 2015-09-30 | 9.06M shares 10-Q · filed 2016-11-10 | |||||||
| 2015-06-30 | 7.73M shares 10-Q · filed 2016-08-09 | |||||||
| 2014-12-31 | 7.63M shares 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |